Form 10-Q · Quarterly report
Ametek 10-Q, filed Nov 3, 2026
- Filed
- CIK
- 0001037868
- Accession no.
- 0001037868-26-000196
Summary
Ametek reported record third-quarter 2026 results, with net sales of $2,220.3 million (up 17.3% from $1,892.6 million a year earlier), net income of $426.3 million, and diluted EPS of $1.85, driven by a 10% organic sales increase plus a 7% contribution from the acquisitions of FARO Technologies, LKC Technologies, First Aviation Services, and Indicor Instrumentation. The quarter included $27.8 million of pre-tax Indicor-related acquisition costs, and orders rose to a record $2,650.6 million with backlog of $4,540.5 million at September 30, 2026.
Key points
- Diluted earnings per share were a record $1.85, up 15.6% from $1.60 a year earlier.
- Consolidated operating income was a record $584.9 million, or 26.3% of net sales, up 19.8%.
- Orders for the quarter were a record $2,650.6 million, up 34.7%, with 17% organic order growth and 18% from acquisitions.
- First-nine-month 2026 net sales were $6,193.1 million, up 14.6% from $5,402.7 million.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Results of Operations For the quarter ended September 30, 2026, the Company delivered record sales, operating income, net income, and diluted EPS, supported by strong operating margins. Contributions from the acquisitions of FARO Technologies ("FARO") in July 2025, LKC Technologies ("LKC") in January 2026, First Aviation Services ("First Aviation") in May 2026, and Indicor Instrumentation ("Indicor") in August 2026 (collectively, the "recent acquisitions"), together with the Company's Operational Excellence initiatives, contributed favorably to the Company's third-quarter 2026 results. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.